This information is intended for healthcare professionals in Singapore only
Spikevax JN.1
0.1 mg/mL dispersion for injection
Spikevax JN.1 is indicated for active immunisation to prevent COVID-19 caused by SARS-CoV-2 in individuals 6 months of age and older.
Tools
Contact Moderna
How can we help you?
Report a side effect: Adverse Event Intake Portal
Email us: WeCare@modernatx.com
Call us: 1-800-622-4937 Monday - Friday 9:00 AM to 5:00 PM SGT (closed holidays)